We also identified therapy-associated upregulation of several immune checkpoints including CTLA-4, PD-1, and Tim-3, which may reflect acute T-cell activation, but also underscores the potential for subsequent T-cell exhaustion/dysfunction and tumor immune escape. The gene discussed is CTLA4; the disease is neoplasm.